A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Clinical trial NCT06016062 · RECRUITING
Trial details
- NCT number
- NCT06016062
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2025-12-31
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.